Medicalgorithmics ends the first quarter of this year with a 51% increase in revenue and positive EBITDA
Medicalgorithmics S.A., the developer of globally innovative AI algorithms and ECG analysis platforms, has closed the first quarter of 2026 with estimated consolidated sales revenue of PLN 10.2 million, representing a year-on-year increase of 51%. The Company also reported a positive estimated EBITDA of PLN 1.0 million. In the previous quarter, the Company signed three new contracts and expanded one of its existing partnerships to include, amongst other things, the distribution of VCAST technology.